Pharma Owners Accused of Lying About Oxycontin
A court filing appears to link the family that owns Purdue Pharma with specific decisions the company made about the marketing of OxyContin, which contributed to the U.S. opioid epidemic, The New York Times reported. (Source: WebMD Health)
Source: WebMD Health - January 16, 2019 Category: Consumer Health News Source Type: news

Prosecutor Claims Drug Maker Pushed OxyContin Despite Danger Signs
BOSTON (AP) — A member of the family that owns OxyContin maker Purdue Pharma told people at the prescription opioid painkiller's launch party in the 1990s that it would be "followed by a blizzard of prescriptions that will bury the competition," according to court documents filed Tuesday. The details were made public in a case brought by Massachusetts Attorney General Maura Healey that accuses Purdue Pharma, its executives and members of the Sackler family of deceiving patients and doctors about the risks of opioids and pushing prescribers to keep patients on the drug longer. The documents provide informati...
Source: JEMS: Journal of Emergency Medical Services News - January 16, 2019 Category: Emergency Medicine Tags: News Patient Care Administration and Leadership Source Type: news

Prosecutor Claims Drug Maker Pushed OxyContin Despite Danger Signs
BOSTON (AP) — A member of the family that owns OxyContin maker Purdue Pharma told people at the prescription opioid painkiller's launch party in the 1990s that it would be "followed by a blizzard of prescriptions that will bury the competition," according to court documents filed Tuesday. The details were made public in a case brought by Massachusetts Attorney General Maura Healey that accuses Purdue Pharma, its executives and members of the Sackler family of deceiving patients and doctors about the risks of opioids and pushing prescribers to keep patients on the drug longer. The documents provide informati...
Source: JEMS Patient Care - January 16, 2019 Category: Emergency Medicine Tags: News Patient Care Administration and Leadership Source Type: news

OxyContin maker promised 'a blizzard of prescriptions that will bury the competition'
OxyContin and Purdue Pharma are at the center of lawsuits across the country accusing the drug industry of being responsible for an opioid crisis that killed 72,000 Americans in 2017. (Source: the Mail online | Health)
Source: the Mail online | Health - January 16, 2019 Category: Consumer Health News Source Type: news

Prosecutor: Drug maker pushed OxyContin despite danger signs
Massachusetts court filing says company that makes opioid sought 'blizzard of prescriptions' when it launched the drug in the 1990s (Source: ABC News: Health)
Source: ABC News: Health - January 16, 2019 Category: Consumer Health News Tags: Health Source Type: news

​Sacklers directed efforts to mislead public about OxyContin, new documents indicate
When evidence of growing abuse of the drug became clear in the early 2000s, then-president of Purdue Pharma, Richard Sackler, advised pushing blame onto people who had become addicted. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 16, 2019 Category: Health Management Authors: Barry Meier Source Type: news

​Sacklers directed efforts to mislead public about OxyContin, new documents indicate
When evidence of growing abuse of the drug became clear in the early 2000s, then-president of Purdue Pharma, Richard Sackler, advised pushing blame onto people who had become addicted. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 16, 2019 Category: Biotechnology Authors: Barry Meier Source Type: news

Health Highlights: Jan. 16, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Purdue Pharma Owners Lied About Dangers of OxyContin: Court Filing The family that owns OxyContin maker Purdue Pharma directed attempts to play... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 16, 2019 Category: General Medicine Source Type: news

Purdue Pharma Owners Lied About Dangers of OxyContin: Court Filing
Title: Purdue Pharma Owners Lied About Dangers of OxyContin: Court FilingCategory: Health NewsCreated: 1/16/2019 12:00:00 AMLast Editorial Review: 1/16/2019 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - January 16, 2019 Category: Anesthesiology Source Type: news

Sacklers Directed Efforts to Mislead Public About OxyContin, New Documents Indicate
A filing in a Massachusetts lawsuit contains dozens of internal Purdue Pharma documents suggesting the family was far more involved than the company has long contended. (Source: NYT Health)
Source: NYT Health - January 16, 2019 Category: Consumer Health News Authors: BARRY MEIER Tags: Drugs (Pharmaceuticals) Drug Abuse and Traffic OxyContin (Drug) Addiction (Psychology) Opioids and Opiates Suits and Litigation (Civil) Purdue Pharma Richard Sackler Massachusetts Source Type: news

Filing: OxyContin maker forecast 'blizzard of prescriptions'
Massachusetts court filing says company that makes opioid sought 'blizzard of prescriptions' when it launched the drug in the 1990s (Source: ABC News: Health)
Source: ABC News: Health - January 15, 2019 Category: Consumer Health News Tags: Health Source Type: news

Documents: OxyContin maker boasted about potential sales
A member of the family that owns OxyContin maker Purdue Pharma told people gathered at the prescription opioid painkiller's launch party in the 1990s that it would be "followed by a blizzard of prescriptions that will bury the competition" (Source: ABC News: Health)
Source: ABC News: Health - January 15, 2019 Category: Consumer Health News Tags: Health Source Type: news

Family behind Purdue Pharma pushed opioid marketing, Massachusetts says
Members of the wealthy Sackler family behind Purdue Pharma LP personally pushed the company to boost sales of OxyContin and other opioid products even as questions emerged about the extent its painkillers were being abused, Massachusetts' attorney general alleged on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

RoxyBond (Oxycodone Hydrochloride Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 8, 2019 Category: Drugs & Pharmacology Source Type: news

Medical News Today: What to know about oxycodone
Oxycodone is an opioid drug that doctors prescribe to help manage moderate to severe pain. In this article, we look at the uses, risks, and effectiveness of oxycodone, along with its addictive potential. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 4, 2019 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Updated lawsuit teases new details against OxyContin maker
An updated complaint in Massachusetts' lawsuit against Purdue Pharma claims members of the family that owns the OxyContin maker are personally responsible for fueling abuse of the deadly painkiller (Source: ABC News: Health)
Source: ABC News: Health - December 22, 2018 Category: Consumer Health News Tags: Health Source Type: news

MORE DANGEROUS than a nuclear weapon, Fentanyl – the heroin-based prescription painkiller – could be the next WMD
(Natural News) Opioids are the class of pain-relieving drugs made from the illegal and deadly drug heroin. Fentanyl is by far the most dangerous, but you’ve certainly heard of some other popular ones, including oxycodone (a.k.a. Oxycontin), hydrocodone (a.k.a. Vicodin), morphine and codeine. Fentanyl is so strong that just a few too many milligrams can... (Source: NaturalNews.com)
Source: NaturalNews.com - December 19, 2018 Category: Consumer Health News Source Type: news

Court: Testimony from OxyContin maker must be unsealed
A Kentucky appeals court says the secret testimony from a former president of one of the world's largest manufacturers of dangerously addictive opioid painkillers must be released to the public (Source: ABC News: Health)
Source: ABC News: Health - December 14, 2018 Category: Consumer Health News Tags: Health Source Type: news

FDA rejects reformulated opioid
Mallinckrodt announced this week that the FDA will not approve an abuse-deterrent version of the company ’s opioid product, Roxicodone. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 12, 2018 Category: Pharmaceuticals Source Type: news

CDC Identifies Drugs Frequently Involved in Drug Overdose Deaths
Oxycodone, heroin, and fentanyl ranked first in 2011, 2012 - 2015, 2016; cocaine ranked second or third (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - December 12, 2018 Category: Psychiatry Tags: Family Medicine, Gynecology, Internal Medicine, Emergency Medicine, Nursing, Pharmacy, Psychiatry, Journal, Source Type: news

Overdose Deaths Involving Fentanyl Doubled Every Year From 2013 to 2016
Drug overdose deaths involving the potent synthetic opioid fentanyl are on the rise, and the number of fentanyl-related deaths roughly doubled each year from 2013 through 2016, according to new federal data. Researchers from the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics (NCHS) reviewed death certificates filed from 2011 to 2016 to find out which drugs were mentioned most frequently each year. During this time period, drug overdose deaths increased from 41,340 in 2011 to 63,632 in 2016. Just as striking as the overall uptick, however, was the sharp increase in deaths invo...
Source: TIME: Health - December 12, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime public health Source Type: news

FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller
The U.S. Food and Drug Administration has declined to approve an abuse-deterrent version of Mallinckrodt Plc's opioid painkiller Roxicodone, saying some parts of the company's application need further evaluation. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

CDC Identifies Drugs Frequently Involved in Drug Overdose Deaths
WEDNESDAY, Dec. 12, 2018 -- The drugs most commonly involved in drug overdose deaths during 2011 to 2016 include fentanyl, heroin, oxycodone, and cocaine, according to the Dec. 12 issue of the National Vital Statistics Reports, a publication from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2018 Category: Pharmaceuticals Source Type: news

FDA declines to approve reformulated Mallinckrodt opioid
Mallinckrodt Plc said on Wednesday the U.S. Food and Drug Administration declined to approve an abuse-deterrent version of its opioid painkiller Roxicodone. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Six Michigan Doctors Charged in $464 Million Insurance and Opioid Scheme
Federal prosecutors said the doctors unnecessarily prescribed opioids to patients and sought to defraud insurance companies. (Source: NYT Health)
Source: NYT Health - December 7, 2018 Category: Consumer Health News Authors: LAURA M. HOLSON Tags: Frauds and Swindling Opioids and Opiates Health Insurance and Managed Care Michigan OxyContin (Drug) Medicaid Medicare Rajendra Bothra, Eric Backos Ganiu Edu David Lewis Christopher Russo Ronald Kufner Source Type: news

Study Shows Cancer Patients Can Benefit from Opioid Switching
Switching from one prescription opioid to another often solves the problem of debilitating side effects or inadequate pain relief, according to a recent study involving a wide range of cancer patients. Opioids are not all the same. And neither are those they are helping. Despite the increasing government restrictions and the frenzy over potential abuse, opioids can be a lifesaver for a mesothelioma patient finding the right fit. “I’ve been through both sides of that switching issue,” said Tim Crisler, a 16-year pleural mesothelioma survivor told The Mesothelioma Center at Asbestos.com. “It worked gr...
Source: Asbestos and Mesothelioma News - November 26, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Repeated blast model of mild traumatic brain injury alters oxycodone self-administration and drug seeking - Nawarawong NN, Slaker M, Muelbl M, Shah AS, Chiariello R, Nelson LD, Budde MD, Stemper BD, Olsen CM.
Each year, traumatic brain injuries (TBI) affect millions worldwide. Mild TBIs (mTBI) are the most prevalent and can lead to a range of neurobehavioral problems, including substance abuse. A single blast exposure, inducing mTBI alters the medial prefrontal... (Source: SafetyLit)
Source: SafetyLit - November 22, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

FDA Panels Recommend Approval of Abuse-Deterrent IR Oxycodone FDA Panels Recommend Approval of Abuse-Deterrent IR Oxycodone
Two FDA advisory committees voted 10-7 for recommending approval for a new abuse-deterrent formulation of immediate-release (IR) oxycodone to treat adult patients with severe pain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Abuse-Deterrent Oxycodone Ekes Out FDA Panel Win
(MedPage Today) -- 10-7 vote in joint advisory committee meeting favoring MNK-812 approval (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 15, 2018 Category: American Health Source Type: news

New Abuse-Deterrent IR Oxycodone Drug to Be Reviewed
(MedPage Today) -- MNK-812 employs multiple technologies to make snorting painful and injection difficult (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 13, 2018 Category: Psychiatry Source Type: news

Blue Cross making changes to opioid policy in 2019
Blue Cross and Blue Shield of Alabama is making changes to the way it handles opioids. Alabama's largest health insurer said it is changing its opioid management strategy for its commercial members in 2019 as part of a larger effort to combat the opioid epidemic. Blue Cross said it will cover Roxybond, the new instant release oxycodone formulation that is considered an “abuse de terrent” by the Food and Drug Administration. Lucemyra, the first non—opioid approved drug to treat the symptoms… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2018 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Blue Cross making changes to opioid policy in 2019
Blue Cross and Blue Shield of Alabama is making changes to the way it handles opioids. Alabama's largest health insurer said it is changing its opioid management strategy for its commercial members in 2019 as part of a larger effort to combat the opioid epidemic. Blue Cross said it will cover Roxybond, the new instant release oxycodone formulation that is considered an “abuse de terrent” by the Food and Drug Administration. Lucemyra, the first non—opioid approved drug to treat the symptoms… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 7, 2018 Category: Biotechnology Authors: Tyler Patchen Source Type: news

She drank kratom tea while pregnant. Then her newborn went into withdrawal
The woman had used oxycodone for almost a decade but told her doctors she had been sober for two years. She never touched narcotics during her pregnancy, she said, and had completed rehab. (Source: CNN.com - Health)
Source: CNN.com - Health - November 7, 2018 Category: Consumer Health News Source Type: news

Rx Switching at the Pharmacy: What would you say?
Should you substitute  Vigamox with Moxeza? How about Oxycontin with MS Contin? Take our quick, 4-question quiz to find out.  (Source: ConsultantLive)
Source: ConsultantLive - November 1, 2018 Category: Internal Medicine Authors: Alex Evans, PharmD, BCGP Source Type: news

Comparison of Oxycodone and Morphine for Cancer Pain Comparison of Oxycodone and Morphine for Cancer Pain
Do oxycodone and morphine differ significantly in their analgesic efficacy or tolerability when used as first-line therapy for patients with moderate to severe cancer pain?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2018 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Roxicodone (Oxycodone Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 24, 2018 Category: Drugs & Pharmacology Source Type: news

SpineThera gets a potential suitor: The maker of OxyContin
A non-opioid painkiller being developed by Plymouth-based SpineThera Inc. has caught the eye of Purdue Pharma, the maker of OxyContin, which has signed a deal to give the Connecticut pharmaceutical company the exclusive option to acquire SpineThera. The companies announced the deal, which also includes granting worldwide rights for SpineThera's key SX600 drug to Stamford, Conn.-based Purdue, on Monday. Terms weren't disclosed. “We are committed to alleviating pain through new and innovative… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 23, 2018 Category: Biotechnology Authors: Mark Reilly Source Type: news

U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone(R) (Oxycodone Hydrochloride)
Company Seeks Approval of New Drug Application for MNK-812 Through 505(b)2 Regulatory Pathway STAINES-UPON-THAMES, United Kingdom, Oct. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharma... Biopharmaceuticals, Drug Delivery, FDA Mallinckrodt, Roxicodone, Oxycodone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 8, 2018 Category: Pharmaceuticals Source Type: news

U.S. hospitals overrun by babies dependent on opioids
(Natural News) Opioids are a class of strong prescription painkillers which are incredibly addictive. Initially prescribed as a pain management tool for cancer sufferers, in the early 1990s drug giant Purdue Pharma started aggressively pitching them to doctors as an effective treatment for chronic pain. In just six years, prescriptions for Purdue’s star product – OxyContin... (Source: NaturalNews.com)
Source: NaturalNews.com - October 2, 2018 Category: Consumer Health News Source Type: news

Percodan (Aspirin and Oxycodone Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 19, 2018 Category: Drugs & Pharmacology Source Type: news

Tennessee nurse wrote herself prescriptions for over 10,000 opioids and muscle relaxers
Tennessee nurse Patricia Tillis, 61, had been suspended after writing herself 104 prescriptions over three years. She used a pre-signed prescription pad to give herself oxycodone and Soma. (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2018 Category: Consumer Health News Source Type: news

Oregon AG Rosenblum accuses OxyContin maker of deceptive marketing
Purdue Pharma targeted Oregon seniors in a deceptive marketing campaign for the opioid painkiller OxyContin and lied to the Oregon Board to Pharmacy to boost its profits, Attorney General Ellen Rosenblum alleged in a lawsuit filed Thursday. Purdue misrepresented the risks and benefits of the drug and engaged in a pattern of racketeering and other misleading activity, according to the complaint filed in Multnomah County Circuit Court. Rosenblum contends Purdue violated a stipulated Oregon judgment… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 14, 2018 Category: American Health Authors: Elizabeth Hayes Source Type: news

Is extra monitoring a solution for opioid abuse? Proposal would send high-dose users to special pain units
(Natural News) British doctors are calling for stricter rules in the management of painkillers in order to fight the opioid addiction epidemic. These medical professionals are now suggesting that patients who are given highly powerful opioids such as oxycodone and tramadol should be referred to special pain units who would then conduct monthly reviews. The... (Source: NaturalNews.com)
Source: NaturalNews.com - September 11, 2018 Category: Consumer Health News Source Type: news

Elderly Couple Who Ran Manhattan'Pill Mill' Headed to Jail Elderly Couple Who Ran Manhattan'Pill Mill' Headed to Jail
Rogelio Lucas and his wife and office manager are sentenced to jail for flooding New York City streets with more than 3 million oxycodone pills worth nearly $80 million.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Elderly Doctor, Wife Who Ran NYC'Pill Mill' Headed to Jail Elderly Doctor, Wife Who Ran NYC'Pill Mill' Headed to Jail
Rogelio Lucas and his wife and office manager are sentenced to jail for flooding New York City streets with more than 3 million oxycodone pills worth nearly $80 million.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Oxycontin ’ s Maker Now Selling Drug to Curb Opioid Addiction
New anti - addiction drug is fast - acting form of buprenorphine, which helps control drug cravings (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 11, 2018 Category: Psychiatry Tags: Pharmacy, Psychiatry, Anesthesiology & amp; Pain, Institutional, Source Type: news

OxyContin maker reportedly patents drug to treat opioid addiction
Purdue Pharma has reportedly received a patent for a medication to fight opioid addiction. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 10, 2018 Category: Pharmaceuticals Source Type: news

Oxycontin Maker Selling Opioid Addiction Drug, Too
The new anti-addiction drug is a fast-acting form of buprenorphine, which helps control drug cravings, CBS News reported. (Source: WebMD Health)
Source: WebMD Health - September 10, 2018 Category: Consumer Health News Source Type: news

Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
MONDAY, Sept. 10, 2018 -- Purdue Pharma, the maker of Oxycontin who some have blamed for the epidemic of opioid painkiller addictions, has patented a medicine aimed at curbing those disorders. The new anti-addiction drug is a fast-acting form of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 10, 2018 Category: Pharmaceuticals Source Type: news